[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.106.142. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
International Data Corporation. Worldwide quarterly wearables device tracker. Published June 21, 2017.
2.
Althoff  T, Sosič  R, Hicks  JL, King  AC, Delp  SL, Leskovec  J.  Large-scale physical activity data reveal worldwide activity inequality.  Nature. 2017;547(7663):336-339. doi:10.1038/nature23018PubMedGoogle ScholarCrossref
3.
Fitbit staff. The magic of 10,000 steps. https://blog.fitbit.com/the-magic-of-10000-steps/. Published June 22, 2010. Accessed November 28, 2018.
4.
Torjesen  I.  Sixty seconds on . . . exercise.  BMJ. 2018;362:k3006. doi:10.1136/bmj.k3006PubMedGoogle ScholarCrossref
5.
Hatano  Y.  Prevalence and use of pedometer.  Res J Walking. 1997;1(1):45-54.Google Scholar
6.
Tudor-Locke  C, Bassett  DR  Jr.  How many steps/day are enough? Preliminary pedometer indices for public health.  Sports Med. 2004;34(1):1-8. doi:10.2165/00007256-200434010-00001PubMedGoogle ScholarCrossref
7.
Bassett  DR  Jr, Toth  LP, LaMunion  SR, Crouter  SE.  Step counting: a review of measurement considerations and health-related applications.  Sports Med. 2017;47(7):1303-1315. doi:10.1007/s40279-016-0663-1PubMedGoogle ScholarCrossref
8.
Ponsonby  AL, Sun  C, Ukoumunne  OC,  et al.  Objectively measured physical activity and the subsequent risk of incident dysglycemia: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab).  Diabetes Care. 2011;34(7):1497-1502. doi:10.2337/dc10-2386PubMedGoogle ScholarCrossref
9.
Dwyer  T, Ponsonby  AL, Ukoumunne  OC,  et al.  Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study.  BMJ. 2011;342:c7249. doi:10.1136/bmj.c7249PubMedGoogle ScholarCrossref
10.
Herzig  KH, Ahola  R, Leppäluoto  J, Jokelainen  J, Jämsä  T, Keinänen-Kiukaanniemi  S.  Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT.  Int J Obes (Lond). 2014;38(8):1089-1096. doi:10.1038/ijo.2013.224PubMedGoogle ScholarCrossref
11.
Huffman  KM, Sun  JL, Thomas  L,  et al.  Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.  Metabolism. 2014;63(4):554-561. doi:10.1016/j.metabol.2014.01.002PubMedGoogle ScholarCrossref
12.
Yates  T, Davies  MJ, Haffner  SM,  et al.  Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial.  Diabet Med. 2015;32(8):1090-1096. doi:10.1111/dme.12762PubMedGoogle ScholarCrossref
13.
Kraus  WE, Yates  T, Tuomilehto  J,  et al.  Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.  BMJ Open Diabetes Res Care. 2018;6(1):e000523. doi:10.1136/bmjdrc-2018-000523PubMedGoogle ScholarCrossref
14.
Yates  T, Haffner  SM, Schulte  PJ,  et al.  Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.  Lancet. 2014;383(9922):1059-1066. doi:10.1016/S0140-6736(13)62061-9PubMedGoogle ScholarCrossref
15.
Dwyer  T, Pezic  A, Sun  C,  et al.  Objectively measured daily steps and subsequent long term all-cause mortality: the Tasped Prospective Cohort Study.  PLoS One. 2015;10(11):e0141274. doi:10.1371/journal.pone.0141274PubMedGoogle ScholarCrossref
16.
Yamamoto  N, Miyazaki  H, Shimada  M,  et al.  Daily step count and all-cause mortality in a sample of Japanese elderly people: a cohort study.  BMC Public Health. 2018;18(1):540. doi:10.1186/s12889-018-5434-5PubMedGoogle ScholarCrossref
17.
Jefferis  BJ, Parsons  TJ, Sartini  C,  et al.  Objectively measured physical activity, sedentary behaviour and all-cause mortality in older men: does volume of activity matter more than pattern of accumulation?  Br J Sports Med. 2018;bjsports-2017-098733. doi:10.1136/bjsports-2017-098733PubMedGoogle Scholar
18.
Physical Activity Guidelines Advisory Committee. 2018 Physical activity guidelines advisory committee report. https://health.gov/paguidelines/second-edition/report/. Published February 2018. Accessed November 29, 2018.
19.
Stamatakis  E, Kelly  P, Strain  T, Murtagh  EM, Ding  D, Murphy  MH.  Self-rated walking pace and all-cause, cardiovascular disease and cancer mortality: individual participant pooled analysis of 50 225 walkers from 11 population British cohorts.  Br J Sports Med. 2018;52(12):761-768. doi:10.1136/bjsports-2017-098677PubMedGoogle ScholarCrossref
20.
Wang  H, Zhang  YF, Xu  LL, Jiang  CM.  Step rate–determined walking intensity and walking recommendation in Chinese young adults: a cross-sectional study.  BMJ Open. 2013;3(1):e001801. doi:10.1136/bmjopen-2012-001801PubMedGoogle ScholarCrossref
21.
Cook  NR, Lee  IM, Gaziano  JM,  et al.  Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial.  JAMA. 2005;294(1):47-55. doi:10.1001/jama.294.1.47PubMedGoogle ScholarCrossref
22.
Lee  I-M, Cook  NR, Gaziano  JM,  et al.  Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial.  JAMA. 2005;294(1):56-65. doi:10.1001/jama.294.1.56PubMedGoogle ScholarCrossref
23.
Ridker  PM, Cook  NR, Lee  IM,  et al.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.  N Engl J Med. 2005;352(13):1293-1304. doi:10.1056/NEJMoa050613PubMedGoogle ScholarCrossref
24.
Lee  I-M, Shiroma  EJ, Evenson  KR, Kamada  M, LaCroix  AZ, Buring  JE.  Using devices to assess physical activity and sedentary behavior in a large cohort study: the Women’s Health Study.  J Meas Phys Behav. 2018;1(2):60-69. doi:10.1123/jmpb.2018-0005PubMedGoogle ScholarCrossref
25.
Choi  L, Liu  Z, Matthews  CE, Buchowski  MS.  Validation of accelerometer wear and nonwear time classification algorithm.  Med Sci Sports Exerc. 2011;43(2):357-364. doi:10.1249/MSS.0b013e3181ed61a3PubMedGoogle ScholarCrossref
26.
Choi  L, Ward  SC, Schnelle  JF, Buchowski  MS.  Assessment of wear/nonwear time classification algorithms for triaxial accelerometer.  Med Sci Sports Exerc. 2012;44(10):2009-2016. doi:10.1249/MSS.0b013e318258cb36PubMedGoogle ScholarCrossref
27.
Tudor-Locke  C, Camhi  SM, Troiano  RP.  A catalog of rules, variables, and definitions applied to accelerometer data in the National Health and Nutrition Examination Survey, 2003-2006.  Prev Chronic Dis. 2012;9:E113.PubMedGoogle Scholar
28.
Tudor-Locke  C, Han  H, Aguiar  EJ,  et al.  How fast is fast enough? Walking cadence (steps/min) as a practical estimate of intensity in adults: a narrative review.  Br J Sports Med. 2018;52(12):776-788. doi:10.1136/bjsports-2017-097628PubMedGoogle ScholarCrossref
29.
Shiroma  EJ, Sesso  HD, Moorthy  MV, Buring  JE, Lee  I-M.  Do moderate-intensity and vigorous-intensity physical activities reduce mortality rates to the same extent?  J Am Heart Assoc. 2014;3(5):e000802. doi:10.1161/JAHA.114.000802PubMedGoogle ScholarCrossref
30.
Desquilbet  L, Mariotti  F.  Dose-response analyses using restricted cubic spline functions in public health research.  Stat Med. 2010;29(9):1037-1057.PubMedGoogle Scholar
31.
Willett  W, Stampfer  MJ.  Total energy intake: implications for epidemiologic analyses.  Am J Epidemiol. 1986;124(1):17-27. doi:10.1093/oxfordjournals.aje.a114366PubMedGoogle ScholarCrossref
32.
Arem  H, Moore  SC, Patel  A,  et al.  Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship.  JAMA Intern Med. 2015;175(6):959-967. doi:10.1001/jamainternmed.2015.0533PubMedGoogle ScholarCrossref
33.
Schuna  JM  Jr, Brouillette  RM, Foil  HC, Fontenot  SL, Keller  JN, Tudor-Locke  C.  Steps per day, peak cadence, body mass index, and age in community-dwelling older adults.  Med Sci Sports Exerc. 2013;45(5):914-919. doi:10.1249/MSS.0b013e31827e47acPubMedGoogle ScholarCrossref
34.
Tudor-Locke  C, Brashear  MM, Katzmarzyk  PT, Johnson  WD.  Peak stepping cadence in free-living adults: 2005-2006 NHANES.  J Phys Act Health. 2012;9(8):1125-1129. doi:10.1123/jpah.9.8.1125PubMedGoogle ScholarCrossref
35.
Oja  P, Kelly  P, Murtagh  EM, Murphy  MH, Foster  C, Titze  S.  Effects of frequency, intensity, duration and volume of walking interventions on CVD risk factors: a systematic review and meta-regression analysis of randomised controlled trials among inactive healthy adults.  Br J Sports Med. 2018;52(12):769-775. doi:10.1136/bjsports-2017-098558PubMedGoogle ScholarCrossref
36.
Kelly  P, Kahlmeier  S, Götschi  T,  et al.  Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship.  Int J Behav Nutr Phys Act. 2014;11:132. doi:10.1186/s12966-014-0132-xPubMedGoogle ScholarCrossref
37.
US Department of Health and Human Services. Physical activity guidelines for Americans, 2nd edition. https://health.gov/paguidelines/second-edition/pdf/Physical_Activity_Guidelines_2nd_edition.pdf. Published 2018. Accessed November 29, 2018.
38.
Jordan  AN, Jurca  GM, Locke  CT, Church  TS, Blair  SN.  Pedometer indices for weekly physical activity recommendations in postmenopausal women.  Med Sci Sports Exerc. 2005;37(9):1627-1632. doi:10.1249/01.mss.0000177455.58960.aaPubMedGoogle ScholarCrossref
39.
Bravata  DM, Smith-Spangler  C, Sundaram  V,  et al.  Using pedometers to increase physical activity and improve health: a systematic review.  JAMA. 2007;298(19):2296-2304. doi:10.1001/jama.298.19.2296PubMedGoogle ScholarCrossref
40.
Campos  C, DePaul  VG, Knorr  S, Wong  JS, Mansfield  A, Patterson  KK.  Validity of the ActiGraph activity monitor for individuals who walk slowly post-stroke.  Top Stroke Rehabil. 2018;25(4):295-304. doi:10.1080/10749357.2018.1446487PubMedGoogle ScholarCrossref
41.
Toth  LP, Park  S, Springer  CM, Feyerabend  MD, Steeves  JA, Bassett  DR.  Video-recorded validation of wearable step counters under free-living conditions.  Med Sci Sports Exerc. 2018;50(6):1315-1322. doi:10.1249/MSS.0000000000001569PubMedGoogle ScholarCrossref
42.
Keadle  SK, Shiroma  EJ, Kamada  M, Matthews  CE, Harris  TB, Lee  I-M.  Reproducibility of accelerometer-assessed physical activity and sedentary time.  Am J Prev Med. 2017;52(4):541-548. doi:10.1016/j.amepre.2016.11.010PubMedGoogle ScholarCrossref
43.
Bassett  DR  Jr, Wyatt  HR, Thompson  H, Peters  JC, Hill  JO.  Pedometer-measured physical activity and health behaviors in US adults.  Med Sci Sports Exerc. 2010;42(10):1819-1825. doi:10.1249/MSS.0b013e3181dc2e54PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    5 Comments for this article
    EXPAND ALL
    Really?
    Harry Vu |
    It's hard to fathom how a person's step activity for 7 days could have any influence on their demise 4 years later. Seriously.
    CONFLICT OF INTEREST: None Reported
    Very useful for people taking care of our senior citizens
    Esteban Perez-Wohlfeil, PhD Student | University Of Malaga
    I enjoyed the read.

    Best regards,
    Esteban
    CONFLICT OF INTEREST: None Reported
    Limit of the association of step volume and intensity in mortality rates
    DANIEL LOPEZ-HERNANDEZ, Ph.D M.Sc Physician M.D | Institute of Security and Social Services of State Workers
    The results of the study by Lee et al provide epidemiological evidence of the benefit of walking on all-cause mortality, however, it also generates uncertainties about the analysis of life course and what are the social determinants of health that favored such protection between the different subgroups?

    It is noteworthy that the prevalence of chronic diseases decreases among the different groups of quartiles, this suggests that the lifestyles are different between each group of analysis, therefore, the logical question would be if all the age groups are represented in each quartile.

    In addition, the study provides evidence that
    suggests the implementation of a public health program for active and healthy aging and the later analysis of the results on the prevalence of mortality in this population group.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Correlation/causation
    Jenna Wattenbarger, BA in English | None
    Elderly women who walk more are probably healthier in the first place.
    CONFLICT OF INTEREST: None Reported
    Comparison to 2020 study
    N Prasad |
    Could the authors please comment on their results compared to the 2020 study, which found benefits at 10k and 12k steps/day of walking? The recent study is at:

    Association of Daily Step Count and Step Intensity With Mortality Among US Adults
    Pedro F. Saint-Maurice, PhD1; Richard P. Troiano, PhD2; David R. Bassett Jr, PhD3; et alBarry I. Graubard, PhD1; Susan A. Carlson, PhD4; Eric J. Shiroma, ScD5; Janet E. Fulton, PhD4; Charles E. Matthews, PhD1
    Author Affiliations
    JAMA. 2020;323(12):1151-1160. doi:10.1001/jama.2020.1382
    March 24/31, 2020

    Thanks!
    CONFLICT OF INTEREST: None Reported
    Original Investigation
    May 29, 2019

    Association of Step Volume and Intensity With All-Cause Mortality in Older Women

    Author Affiliations
    • 1Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
    • 2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
    • 3Laboratory of Epidemiology and Population Science, National Institute on Aging, Baltimore, Maryland
    • 4Department of Health and Social Behavior, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    • 5Department of Kinesiology, Recreation, and Sport Studies, University of Tennessee, Knoxville
    • 6Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
    JAMA Intern Med. 2019;179(8):1105-1112. doi:10.1001/jamainternmed.2019.0899
    Key Points

    Question  Are increased numbers of steps per day associated with lower mortality rates among older women?

    Findings  In this cohort study of 16 741 women with a mean age of 72 years, steps per day were measured over 7 days. Women who averaged approximately 4400 steps/d had significantly lower mortality rates during a follow-up of 4.3 years compared with the least active women who took approximately 2700 steps/d; as more steps per day were accrued, mortality rates progressively decreased before leveling at approximately 7500 steps/d.

    Meaning  More steps taken per day are associated with lower mortality rates until approximately 7500 steps/d.

    Abstract

    Importance  A goal of 10 000 steps/d is commonly believed by the public to be necessary for health, but this number has limited scientific basis. Additionally, it is unknown whether greater stepping intensity is associated with health benefits, independent of steps taken per day.

    Objective  To examine associations of number of steps per day and stepping intensity with all-cause mortality.

    Design, Setting, and Participants  This prospective cohort study included 18 289 US women from the Women’s Health Study who agreed to participate by wearing an accelerometer during waking hours for 7 days between 2011 and 2015. A total of 17 708 women wore and returned their devices; data were downloaded successfully from 17 466 devices. Of these women, 16 741 were compliant wearers (≥10 h/d of wear on ≥4 days) and included in the analyses, which took place between 2018 and 2019.

    Exposures  Steps per day and several measures of stepping intensity (ie, peak 1-minute cadence; peak 30-minute cadence; maximum 5-minute cadence; time spent at a stepping rate of ≥40 steps/min, reflecting purposeful steps).

    Main Outcomes and Measures  All-cause mortality.

    Results  Of the 16 741 women who met inclusion criteria, the mean (SD) age was 72.0 (5.7) years. Mean step count was 5499 per day, with 51.4%, 45.5%, and 3.1% of time spent at 0, 1 to 39 (incidental steps), and 40 steps/min or greater (purposeful steps), respectively. During a mean follow-up of 4.3 years, 504 women died. Median steps per day across low-to-high quartiles of distribution were 2718, 4363, 5905, and 8442, respectively. The corresponding quartile hazard ratios (HRs) associated with mortality and adjusted for potential confounders were 1.00 (reference), 0.59 (95% CI, 0.47-0.75), 0.54 (95% CI, 0.41-0.72), and 0.42 (95% CI, 0.30-0.60), respectively (P < .01). In spline analysis, HRs were observed to decline progressively with higher mean steps per day until approximately 7500 steps/d, after which they leveled. For measures of stepping intensity, higher intensities were associated with significantly lower mortality rates; however, after adjusting for steps per day, all associations were attenuated, and most were no longer significant (highest vs lowest quartile for peak 1-minute cadence, HR = 0.87 [95% CI, 0.68-1.11]; peak 30-minute cadence, HR = 0.86 [95% CI, 0.65-1.13]; maximum 5-minute cadence, HR = 0.80 [95% CI, 0.62-1.05]; and time spent at a stepping rate of ≥40 steps/min, HR = 1.27 [95% CI, 0.96-1.68]; P > .05).

    Conclusions and Relevance  Among older women, as few as approximately 4400 steps/d was significantly related to lower mortality rates compared with approximately 2700 steps/d. With more steps per day, mortality rates progressively decreased before leveling at approximately 7500 steps/d. Stepping intensity was not clearly related to lower mortality rates after accounting for total steps per day.

    ×